Anca Chelariu-Raicu

ORCID: 0000-0003-2944-9488 · 4 papers in corpus
other 2022
Scientific reports ·doi:10.1038/s41598-022-05785-9

In recurrent epithelial ovarian cancer (EOC) most patients develop platinum-resistance. On molecular level the NRF2 pathway, a cellular defense mechanism against reactive oxygen species, is induced. In this study, we investigate AKR1C1/2, t…

lab-animal 2020
Molecular cancer therapeutics ·doi:10.1158/1535-7163.mct-19-1026

Abnormal activity of human prolactin (PRL) and its membrane-associated receptor (PRLR) contributes to the progression of uterine carcinoma. However, the underlying mechanisms are not well understood, and current means of targeting the PRL/P…

other 2016
Fertility and sterility ·doi:10.1016/j.fertnstert.2016.03.032

OBJECTIVE: To study the expression and function of syndecan-4 in endometriosis. DESIGN: Histopathological investigation of eutopic endometrium and experimental laboratory study on a cell line derived from epithelial endometriotic cells (12…

2014
·doi:10.1055/s-0034-1388244

Der Begriff Endometriose ist definiert als das Vorkommen von Endometrium oder Endometrium ähnlichem Gewebe außerhalb des Cavum uteri. (Giudice 2010) Die Syndecane sind transmembranöse Rezeptoren auf der Zelloberfläche, die für die Zelladhäs…